Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Winston-Salem, North Carolina 27157


Purpose:

The purpose of this study is to evaluate whether Biaxin (clarithromycin) improves sputum abnormalities, lung function, and overall feeling of well-being in people with cystic fibrosis (CF). Biaxin is an antibiotic commonly used for the treatment of respiratory infections in people who do not have CF, and is sometimes used in CF patients as well. Studies done in a disease called diffuse panbronchiolitis (which is similar to CF) and some preliminary studies that have been done in CF patients suggest that Biaxin might have a beneficial effect on CF sputum in ways unrelated to its antibiotic activity.


Criteria:

Inclusion Criteria: - diagnosis of CF - ability to reliably perform spirometry - FEV1 of 30% predicted at the time of screening Exclusion Criteria: - Mycobacterium in a sputum culture ever recorded - a respiratory exacerbation requiring IV antibiotics in the 60 days prior - used a investigational drug or device in the 60 days prior - significant (>30ml) of hemoptysis in the past year - require oxygen or have significant liver or renal disease


NCT ID:

NCT00205634


Primary Contact:

Principal Investigator
Bruce K Rubin, MEngr,MD,MBA
Wake Forest University Health Sciences


Backup Contact:

N/A


Location Contact:

Winston-Salem, North Carolina 27157
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.